MBX Biosciences | S-8：員工福利計劃證券登記

03/17 08:35 (美東)

MBX Biosciences | 10-K：2024財年年報

03/17 08:15 (美東)

MBX Biosciences | 8-K：MBX Biosciences公佈2024年第四季度和全年財務業績和近期公司亮點

03/17 08:07 (美東)

MBX Biosciences | 4：持股變動聲明-董事 GORDON CARL L

02/19 18:01 (美東)

MBX Biosciences | 4：持股變動聲明-董事 ORBIMED ADVISORS LLC

02/19 17:56 (美東)

MBX Biosciences | 4：持股變動聲明-高管 Hawryluk P. Kent

02/05 16:23 (美東)

MBX Biosciences | 4：持股變動聲明-高管 Bartram Richard

02/05 16:23 (美東)

MBX Biosciences | 4：持股變動聲明-高管 Azoulay Salomon

02/05 16:23 (美東)

MBX Biosciences | 8-K：重大事件

01/07 07:24 (美東)

MBX Biosciences | SC 13G：超過5%持股股東披露文件-Wellington Management Group LLP(9.22%),Wellington Group Holdings LLP(9.22%)等

2024/11/08 10:55 (美東)

MBX Biosciences | 10-Q：季度報表

2024/11/07 08:33 (美東)

MBX Biosciences | 8-K：MBX Biosciences公佈2024年第三季度財務業績並提供業務最新情況

2024/11/07 08:13 (美東)

MBX Biosciences | SC 13G：超過5%持股股東披露文件-P. Kent Hawryluk(5.55%)

2024/11/01 17:42 (美東)

MBX Biosciences | SC 13D：超過5%持股股東披露文件-Norwest Venture Partners XVI, LP(6.4%),Genesis VC Partners XVI, LLC(6.4%)等

2024/09/23 18:09 (美東)

MBX Biosciences | SC 13D：超過5%持股股東披露文件-New Enterprise Associates 17, L.P.(11.4%),NEA Partners 17, L.P.(11.4%)等

2024/09/23 18:09 (美東)

MBX Biosciences | SC 13D：超過5%持股股東披露文件-OrbiMed Advisors LLC(12.0%),OrbiMed Capital GP VII LLC(9.9%)等

2024/09/23 16:38 (美東)

MBX Biosciences | SC 13G：超過5%持股股東披露文件-Deep Track Capital, LP(9.48%),Deep Track Biotechnology Master Fund, Ltd.(9.48%)等

2024/09/23 16:04 (美東)

MBX Biosciences | SC 13D：超過5%持股股東披露文件-James N. Topper(18.8%),Patrick J. Heron(18.8%)等

2024/09/23 10:53 (美東)

MBX Biosciences | SC 13G：超過5%持股股東披露文件-Wellington Biomedical Innovation Master Investors (Cayman) II, L.P.(5.62%)

2024/09/20 10:17 (美東)

MBX Biosciences | 4：持股變動聲明-董事 Mathers Edward T

2024/09/17 20:30 (美東)